Increased levels of circulating endothelial cells in chronic periaortitis as a marker of active disease

Gabriella Moroni(Humanitas University), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Francesca Urgnani(Ospedale Maggiore), Lorenza Mazzeo Moronetti(Ospedale Maggiore), Claudio Ponticelli, Nicoletta Del Papa(University of Milan), D.P. Comina(University of Milan), Wanda Maglione(University of Milan), Claudio Vitali, S Sandri

Kidney International

July 12, 2005

10.1111/j.1523-1755.2005.00434.x

Cited by 30

Related Papers

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

|Annals of the Rheumatic Diseases|2023|913

Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis

|JAMA|2014|739

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

|Blood|2009|433

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

|Journal of Clinical Oncology|2016|394

Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

|The Lancet Diabetes & Endocrinology|2019|383